Company intelligence / Profile preview

Innovative Neurotronics

Reno, Nevada, United Statestouchneurology.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product WalkAide has received FDA clearance and commercial adoption. It uses functional electrical stimulation to improve walking ability in people with foot drop. The device has been recognized with industry awards and adopted by clinicians as a neurorehabilitation tool. No clinical trial pipeline; the product is marketed and used clinically.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (Functional Electrical Stimulation)
Industry: Assistive Medical Devices

Drug pipeline

1 asset

WalkAide System

Commercial

Indications: Foot drop, Upper motor neuron damage, Spinal cord injury

Partnerships

Collaborations with research centers and universities for technology development; no major pharma partnerships disclosed.

Beyond the preview

Go deeper on Innovative Neurotronics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovative Neurotronics.

Explore the full profile